Kronox Lab Sciences Ratios

Kronox Lab Sciences Ltd Ratios

The Kronox Lab Sciences Ltd Ratios page provides a complete fundamental analysis of Kronox Lab Sciences Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Kronox Lab Sciences Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Kronox Lab Sciences Ltd (NSE: KRONOX, BSE: 544187) is currently trading at ₹128.74, with a market capitalization of ₹4.85B. As a major player in the Process industries sector and Chemicals: specialty industry, Kronox Lab Sciences Ltd remains a key stock for fundamental analysis using Kronox Lab Sciences Ltd Ratios.

Kronox Lab Sciences Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Kronox Lab Sciences Ltd P/E ratio currently stands at 20.96, making it one of the most tracked metrics in Kronox Lab Sciences Ltd Ratios.

Historically, the Kronox Lab Sciences Ltd P/E ratio has shown strong fluctuations:

• 2024: 20.96
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The rising Kronox Lab Sciences Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Kronox Lab Sciences Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 5.92.

Historical P/B trend:

• 2024: 5.92
• 2023: 0
• 2022: 0
• 2021: 0

Kronox Lab Sciences Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Kronox Lab Sciences Ltd P/S ratio currently stands at 5.33, an important part of Kronox Lab Sciences Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 5.33
• 2023: 0
• 2022: 0
• 2021: 0

The rising Kronox Lab Sciences Ltd P/S ratio indicates improved revenue valuation by investors.

Kronox Lab Sciences Ltd Price to Cash Flow Ratio (P/CF)

The Kronox Lab Sciences Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 16.44.

Historical Kronox Lab Sciences Ltd Price to Cash Flow Ratio:

• 2024: 16.44
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The rising Kronox Lab Sciences Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Kronox Lab Sciences Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Kronox Lab Sciences Ltd EV currently stands at ₹4.97B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 4.97B
• 2023: 0
• 2022: 0
• 2021: 0

Kronox Lab Sciences Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Kronox Lab Sciences Ltd EV/EBITDA ratio is currently 14.81, a key metric in Kronox Lab Sciences Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 14.81
• 2023: 0
• 2022: 0
• 2021: 0

Higher Kronox Lab Sciences Ltd EV/EBITDA suggests premium valuation.

Kronox Lab Sciences Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Kronox Lab Sciences Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0.08

Kronox Lab Sciences Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Kronox Lab Sciences Ltd ROE currently stands at 32.56%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 32.56
• 2023: 38.48
• 2022: 38.55
• 2021: 40.58

Kronox Lab Sciences Ltd demonstrates strong profitability and efficient capital utilization.

Kronox Lab Sciences Ltd Ratios Analysis Summary

The Kronox Lab Sciences Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Kronox Lab Sciences Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Kronox Lab Sciences Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.